Conference 2008 Home
Conference
2006 Home
Photos | Videos | Reports from Conference | Materials from Conference | Testimonials | Agenda | Scientific
Sessions | Comments
& Suggestions
Scholarships | Awards | International Events | Hotel & Activities | Health Needs |Sponsors & Exhibits | Travel | Registration
Scientific Sessions
Download Scientific Sessions Evaluation Form (PDF) for CME or CEU Credits
View the Scientific Sessions Program (PDF)
Go to: Research | Abstracts
Up to 6.5 CME and nursing CEU credits will be available. |
>Scientific Sessions Reception, 6-9pm
>PH Resource Network (PHRN) Dinner, 6:30-9pm
>Scientific Sessions,
all day
7:00 am to 6:45 pm
PHA is pleased to announce and continue the Scientific Sessions
at Conference 2006! The first, groundbreaking, round of Scientific
Sessions was held at the 2004 Conference in Miami.
This portion of the conference will be oriented primarily to scientists
and clinicians involved with pulmonary hypertension. These sessions
accomplish several goals, providing a venue devoted solely to the
basic and clinical science of pulmonary hypertension and an opportunity
for investigators to discuss how to best continue the research momentum
towards finding a cure for pulmonary hypertension.
Currently, confirmed presentations and presenters include:
- Inflammation in Systemic Vascular Disease: What Can We
Learn?
Paul Ridker, MD, MPH
Eugene Braunwald Professor of Medicine
Harvard Medical School
- Inflammation in Pulmonary Arterial Hypertension
Olivier Sitbon, MD
Hôpital Antoine Béclère, Clamart, France
- Genetics of Pulmonary Arterial Hypertension: Current Status
John Newman, MD
Elsa S. Hanigan Professor of Pulmonary Medicine, Vanderbilt University Medical Center
- Information Needed for Approval of PAH Drugs
Salma Lemtouni
Food and Drug Administration
- Current Experiences with Stress Echocardiography in Pulmonary
Arterial Hypertension
Ekkehard Grunig, MD
Department of Cardiology and Pneumology, University of Heidelberg
- Magnetic Resonance Imaging in Pulmonary Arterial Hypertension
Valentin Fuster, MD, PhD
Mt. Sinai Medical Center, Director, Zena and Michael A. Wiener Cardiovascular Institute and Professor of Cardiology
7:30 – 7:45 Young Investigators Assemble Posters
(Viewing through Sat. June 23) |
8:00 – 8:15 Opening Remarks: Roadmap to a Cure – 2006 |
8:15 – 09:15 Inflammation in Systemic Vascular Disease: What can we learn?
Paul Ridker, MD |
9:15 – 10:15 Inflammation in Pulmonary Arterial Hypertension
Olivier Sitbon, MD |
10:15 – 11:15 Genetics of Pulmonary Arterial Hypertension
John Newman, MD |
11:30 - 12:15 Luncheon
Information Needed for Approval of PAH Drugs
Salma Lemtouni |
1:00 – 2:30 General Conference Opening Session and Journeys
Keynote Address
TBD |
2:45 – 3:45 Current Experiences with Stress Echocardiography in Pulmonary Arterial Hypertension
Ekkehard Grunig, MD |
3:45 – 4:45 Magnetic Resonance Imaging in Pulmonary Arterial Hypertension
Valentin Fuster, MD, Ph D |
4:45 – 5:45 Oral Abstract Presentations
Moderator: Jim Loyd, MD |
5:45 – 6:45 Unopposed Young Investigator Poster Viewing and Discussion |
Highlights from the 2004 Scientific Sessions
If you are interested in conducting research at the PHA Conference, please submit the following materials to the Scientific Sessions Committee of the SLC.
- Letter of request addressed to Greg Elliott, MD, Scientific Sessions Committee Chair
- Brief Description of the research project
- Current institutional IRB approval
Poster Session:
Abstracts invited in areas of:
--Clinical Science (including treatment)
--Basic Science
Five Abstracts will be selected for oral presentation.
Award will be given for top presentation in both Clinical and
Basic category.
Summary of top presentations will be published in future issue
of Advances
in Pulmonary Hypertension.
Although PHA encourages the submission of original abstracts,
abstracts submitted to PHA do not need to be original work.
We are no longer accepting abstracts. Deadline was 2/28/06.
Notification Date: March 15, 2006
Questions? abstract@phassociation.org
Abstract Sample Form (Rich Text Format)
Greg Elliott, MD, Chair
David Langleben, MD
Jim Loyd, MD
Horst Olschewski, MD
Marlene Rabinowitch, MD
Funding for this conference was made possible in part by grant number 1 R13 HL086494-01 from the National Heart, Lung, and Blood Institute. The views expressed in written conference materials or publications and by speakers and moderators do not necessarily reflect the official policies of the Department of Health and Human Services; nor does mention of trade names, commercial practices, or organizations imply endorsement by the U.S. Government.
.
